First real-world insights into medical resource utilization in patients with Waldenström’s macroglobulinemia (WM) treated with zanubrutinib – results from the interim analysis 1 (IA1) of the ARIADNE study

25. Oktober 2024

Greil R., Melchardt T., Dörfel S., von der Heyde E., Illmer T., Nusch A., Schulz C.-O., Janssen J., Schöttker B., Schwarzer A., Medinger T., Kummer D., Woerner S.M., Kisro J., Marschner P., 2024

Download